References
- Marsh JCW, Ball SE, Cavenagh J, et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009;147:43–70. doi: 10.1111/j.1365-2141.2009.07842.x
- Laver J, Castro-Malaspina H, Kernan NA, et al. In vitro interferon-gamma production by cultured T-cells in severe aplastic anaemia: correlation with granulomonopoietic inhibition in patients who respond to anti-thymocyte globulin. Br J Haematol. 1988;69:545–550. doi: 10.1111/j.1365-2141.1988.tb02413.x
- Gascon P, Zoumbos NC, Scala G, et al. Lymphokine abnormalities in aplastic anemia: implications for the mechanism of action of antithymocyte globulin. Blood. 1985;65:407–413.
- Hinterberger W, Adolf G, Bettelheim P, et al. Lymphokine overproduction in severe aplastic anemia is not related to blood transfusions. Blood. 1989;74:2713–2727.
- Shinohara K, Ayame H, Tanaka M, et al. Increased production of tumor necrosis factor alpha by peripheral blood mononuclear cells in the patients with aplastic anemia. Am J Hematol. 1991;37:75–79. doi: 10.1002/ajh.2830370203
- Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108:2509–2519. doi: 10.1182/blood-2006-03-010777
- Voss SD, Hong R, Sondel PM. Severe combined immunodeficiency, interleukin-2 (IL-2), and the IL-2 receptor: experiments of nature continue to point the way. Blood. 1994;83:626–635.
- Yamanouchi J, Rainbow D, Serra P, et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet. 2007;39:329–337. doi: 10.1038/ng1958
- Kagan WA, Ascensão JA, Pahwa RN, et al. Aplastic anemia: presence in human bone marrow of cells that suppress myelopoiesis. Proc Natl Acad Sci. 1976;73:2890–2894. doi: 10.1073/pnas.73.8.2890
- Maciejewski JP, Anderson S, Katevas P, et al. Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure. Br J Haematol. 1994;87:227–234. doi: 10.1111/j.1365-2141.1994.tb04903.x
- Scopes J, Bagnara M, Gordon-Smith EC, et al. Haemopoietic progenitor cells are reduced in aplastic anemia. Br J Haematol. 1994;86:427–430. doi: 10.1111/j.1365-2141.1994.tb04761.x
- Maciejewski JP, Selleri C, Sato T, et al. A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. Blood. 1996;88:1983–1991.
- Nistico A, Young NS. Gamma-interferon gene expression in the bone marrow of patients with aplastic anemia. Ann Intern Med. 1994;120:463–469. doi: 10.7326/0003-4819-120-6-199403150-00003
- Zoumbos N, Gascon P, Djeu J, et al. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci U S A. 1985;82:188–192. doi: 10.1073/pnas.82.1.188
- Sloand E, Kim S, Maciejewski JP, et al. Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood. 2002;100:1185–1191. doi: 10.1182/blood-2002-01-0035
- S1 I, Kaufman DW, Anderson T, et al. The epidemiology of aplastic anemia in Thailand. Blood. 2006 Feb 15;107(4):1299–1307. doi: 10.1182/blood-2005-01-0161
- Stryckmans PA, Dumont JP, Velu T, et al. Cyclosporine in refractory severe aplastic anemia [letter]. (letter). N Engl J Med. 1984;310:655–656. doi: 10.1056/NEJM198403083101013
- Tripathy NK, Nityanand S. Bone marrow and blood plasma levels of IL-8 in aplastic anemia and their relationship with disease severity. Am J Hematol. 2005;79:240–242. doi: 10.1002/ajh.20367
- Dubey S, Shukla P, Nityanand S. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia. Ann Hematol. 2005;84(9):572–577. doi: 10.1007/s00277-005-1022-8